Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Pharmacology

Evaluating in Vivo Efficacy – Toxicity Profile of TEG001 in Humanized Mice Xenografts Against Primary Human AML Disease and Healthy Hematopoietic Cells

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

A Phase I Study of NLG919 for Adult Patients With Recurrent Advanced Solid Tumors

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

Long-Lasting Disease Stabilization in the Absence of Toxicity in Metastatic Lung Cancer Patients Vaccinated With an HLA-A2-restricted Epitope Derived From Indoleamine 2,3 Dioxygenase

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2013English

Automated Image Analysis of NSCLC Biopsies to Predict Response to Anti-Pd-L1 Therapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

A Multi-Center Phase II Study of High Dose Interleukin-2 Sequenced With Vemurafenib in Patients With BRAF-V600 Mutation Positive Metastatic Melanoma

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2018English

Response and Outcomes After Anti-Ctla4 Versus Anti-Pd1 Combined With Stereotactic Body Radiation Therapy for Metastatic Non-Small Cell Lung Cancer: Retrospective Analysis of Two Single-Institution Prospective Trials

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2020English

Sustained Release of Actives With Montanide™ ISA 51 VG and Montanide™ ISA 720 VG, Two Adjuvants Dedicated to Human Therapeutic Vaccines

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Updated Efficacy of Avelumab in Patients With Previously Treated Metastatic Merkel Cell Carcinoma After ≥1 Year of Follow-Up: JAVELIN Merkel 200, a Phase 2 Clinical Trial

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2018English

The IL-15 Superagonist ALT-803 Enhances Anti-Cd20 Antibody-Directed NK Cell ADCC and in Vivo Clearance of B Cell Lymphomas

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

Enrichment and Expansion With Nanoscale Artificial Antigen Presenting Cells for T Cell Adoptive Immunotherapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy